Boba & Boosting with Portal: Next Gen Cell Engineering & Analytics

​Portal is an early-stage biotech company based in Boston, MA. The company, founded in 2023, is focused on commercializing a next generation cell engineering platform to enable novel cell therapies and unique assays for drug discovery. Portal's core technology relies on the rapid mechanical deformation of cells to temporarily disrupt the cell membrane and enable delivery of multiple cargos into cells simultaneously. The company has established over 50 partnerships to date, including with a majority of the top 10 pharma, and is implementing its technology across scales for R&D, high throughput screening, and clinical cell therapies.